More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.65B
EPS
0.6
P/E ratio
31.6
Price to sales
4.24
Dividend yield
--
Beta
1.943573
Previous close
$16.05
Today's open
$15.99
Day's range
$15.97 - $16.41
52 week range
$13.09 - $19.85
show more
CEO
Michael B. Petras
Employees
3000
Headquarters
Broadview Heights, OH
Exchange
Nasdaq Global Select
Shares outstanding
285630846
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Nov 18, 2026

Do Options Traders Know Something About Sotera Health Stock We Don't?
Investors need to pay close attention to SHC stock based on the movements in the options market lately.
Zacks Investment Research • Nov 12, 2026

What Sotera Health (SHC) Said on Its Q3 Earnings Call
Sotera Health NASDAQ: SHC reported third-quarter 2026 revenue growth and higher adjusted EBITDA, while reaffirming its full-year outlook despite softer demand from medical-device customers in Europe that emerged late in the quarter and continued into the start of the fourth quarter.
MarketBeat • Nov 3, 2026

Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 3, 2026

Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
Q3 2026 net revenues increased 4.4% on both an as-reported and constant currency basis (1) , compared to Q3 2025 Q3 2026 net income of $58 million or $0.20 per diluted share Q3 2026 Adjusted EBITDA ( 1 ) increased 3.9%, or 4.0% on a constant currency basis Q3 2026 Adjusted EPS (1) of $0.29, an increase of 12% per diluted share Reaffirming full-year 2026 net revenues growth outlook of 5.25% - 6.75% and Adjusted EBITDA growth outlook of 5.75% - 7.25%, both on a constant currency basis CLEVELAND, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and nine-months ended September 30, 2026. “We are pleased with our third-quarter performance, which included solid top- and bottom-line constant currency growth, along with nearly 100 basis points of sequential Adjusted EBITDA margin expansion,” said Alton Shader, Chief Executive Officer.
GlobeNewsWire • Nov 3, 2026

Sotera Health Company (SHC) Beats Q3 Earnings and Revenue Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.26 per share a year ago.
Zacks Investment Research • Nov 3, 2026

Here's What Key Metrics Tell Us About Sotera Health (SHC) Q3 Earnings
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research • Nov 3, 2026

Sotera Health Announces Third-Quarter 2026 Earnings Release Date
CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m.
GlobeNewsWire • Oct 21, 2026

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers
Sotera Health Company is rated BUY, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins.
Seeking Alpha • Sep 18, 2026

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha • Sep 9, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Sotera Health Company commission-free¹. Build wealth for the long term using automated trading and transfers.